Skip to main content

Hologic Inc. (HOLX) Stock

Hologic Inc. Stock Details, Movements and Public Alerts

Stock Details

Hologic Inc. (HOLX), a prominent company in the life sciences sector within the x-ray apparatus & tubes & related irradiation apparatus industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $66.80. Over the past 52 weeks, it has ranged between $51.90 and $84.67. This places the current price at 78.9% of its 52-week high and 28.7% above its 52-week low. Recent trading volume was recorded at 50. The International Securities Identification Number (ISIN) for this stock is US4365431083.

52-Week High

$84.67

-21.11% from high

52-Week Low

$51.90

+28.71% from low

Avg Daily Volume

50

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

27.32

Above market average

Forward P/E

14.39

Earnings expected to grow

PEG Ratio

1.24

Reasonably valued

Price to Book

3.14

EV/EBITDA

13.97

EPS (TTM)

$2.38

Price to Sales

3.60

Beta

0.55

Less volatile than market

How is HOLX valued relative to its earnings and growth?
Hologic Inc. trades at a P/E ratio of 27.32, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 14.39 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.24 indicates reasonable value when growth is considered.
What is HOLX's risk profile compared to the market?
With a beta of 0.55, Hologic Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 3.14 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

13.80%

Operating Margin

22.20%

Return on Equity

11.80%

Return on Assets

6.92%

Revenue Growth (YoY)

-1.20%

Earnings Growth (YoY)

-15.50%

How profitable and efficient is HOLX's business model?
Hologic Inc. achieves a profit margin of 13.80%, meaning it retains $13.80 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 22.20% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 11.80% and ROA at 6.92%, the company achieves moderate returns on invested capital.
What are HOLX's recent growth trends?
Hologic Inc.'s revenue declined by 1.20% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings decreased by 15.50% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS industry averages for proper context.

Company Size & Market

Market Cap

$14.49B

Shares Outstanding

222.84M

Book Value/Share

$20.73

Asset Type

Common Stock

What is HOLX's market capitalization and position?
Hologic Inc. has a market capitalization of $14.49B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 222.84M shares outstanding, the company's ownership is relatively concentrated. As a participant in the X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS industry, it competes with other firms in this sector.
How does HOLX's price compare to its book value?
Hologic Inc.'s book value per share is $20.73, while the current stock price is $66.80, resulting in a price-to-book (P/B) ratio of 3.22. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$67.27

0.70% upside potential

Analyst Recommendations

Strong Buy

4

Buy

3

Hold

13

Sell

0

Strong Sell

0

How reliable are analyst predictions for HOLX?
20 analysts cover HOLX with 35% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $67.27 implies 0.7% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on HOLX?
Current analyst recommendations:4 Strong Buy, 3 Buy, 13 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 03:43 AM

Technical Indicators

What does HOLX's RSI value tell investors?
RSI data is not available for this stock.
How should traders interpret HOLX's MACD and moving average crossovers?
MACD and moving average data are not available for this stock.

No technical indicators available yet.

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for HOLX and get notified when the price changes.

Stay Ahead of the Market with Hologic Inc. Alerts

Set up price alerts for Hologic Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.